Monthly Archives: February 2021

Germany hails Bidens move to halt Trump-ordered troop cuts – Al Jazeera English

Posted: February 6, 2021 at 8:00 am

Trump planned to pull out about 9,500 of the roughly 34,500 US troops stationed in Germany.

The German government on Friday welcomed President Joe Bidens decision to formally halt the planned withdrawal of US troops from Germany, arguing the troops stationing there is in our mutual interest.

Last year, then-President Donald Trump announced he was going to pull out about 9,500 of the roughly 34,500 US troops stationed in Germany, but the withdrawal never actually began.

Biden said Thursday the pullout would be halted until defence secretary Lloyd Austin reviews Americas troop presence around the globe.

The German government welcomes this announcement, Chancellor Angela Merkels spokesman, Steffen Seibert, told reporters in Berlin. He said: We will remain in contact with the new American administration on its further plans.

We have always been convinced that the stationing of American troops here in Germany serves European and transatlantic security, and so is in our mutual interest, Seibert said. We very much value this close, decades-long cooperation with the Americans forces that are stationed in Germany.

Asked whether Germany would make any concrete offers to persuade the US not to withdraw troops, Seibert said Berlin will follow developments but how these reviews go is an internal American matter.

The US has several key military facilities in Germany, including Ramstein Air Base, the headquarters for US European Command and US Africa Command, and Landstuhl Regional Medical Center, the largest American military hospital outside the United States.

Trumps order met resistance from Congress as well as from within the military, which has long relied on Germany as a key ally and base of operations.

Trump announced the troop cuts after repeatedly accusing Germany of not paying enough for its own defence, calling the longtime NATO ally delinquent for failing to spend 2 percent of its gross domestic product (GDP) on defence, a benchmark that alliance members have pledged to work towards.

See original here:

Germany hails Bidens move to halt Trump-ordered troop cuts - Al Jazeera English

Posted in Donald Trump | Comments Off on Germany hails Bidens move to halt Trump-ordered troop cuts – Al Jazeera English

The Long Read The Trial of Donald Trump BillMoyers.com – BillMoyers.com

Posted: at 8:00 am

President Donald Trump speaks during a press conference at the White House on Feb. 16, 2017. Trump berated the media repeatedly, calling CNN, The New York Times and other outlets "dishonest" and "very fake news" for reporting unfavorable stories about him. (Photo by Jabin Botsford/The Washington Post via Getty Images)

[Editors Note: STEVEN HARPER is a fellow of the American College of Trial Lawyers]

Opening Statement

The answer led the House of Representatives to impeach then President Donald Trump by the largest bipartisan vote in American history. Today we continue the process of holding him accountable for incitement of insurrection against the government of the United States. The Trump Insurrection led directly to at least five deaths, injuries to 140 law enforcement officers and a scar on the heart of our democracy.

So that we all operate from the same set of indisputable facts, lets watch four short videos overviewing the events of January 6, starting with Just Securitys 10-minute excerpt of Trumps 70-minute speech, which ignited an insurrection that Trump had fomented for months. Notice the mobs reaction as Trump spoke line after incendiary line.

The second video is the Washington Posts 14-minute encapsulation of the 41 minutes that followed Trumps diatribe.

RELATED: Democracy & Government

BY Steven Harper | February 1, 2021

The third video, taken by a reporter for The New Yorker, is a view from inside the mob.

The fourth and final video comes from the bodycam of a law enforcement officer trying to protect the citadel of democracy that day. Watch the mob beat him with hockey sticks and flagpoles ripped from the temporary presidential inauguration structure.

Everything that you just saw and heard actually indisputably happened on January 6, 2021 in the United States of America. How did it come to this?

The story begins six months earlier.

Let the evidence speak for itself.

But Trump wasnt willing to abide by the judicial branchs reaffirmation of his election loss. As court after court rejected his claims, he was pursuing a final backup plan an attack on the legislative branch that, if successful, would nullify the will of the voters and all of his courtroom losses. The Trump Insurrection targeted January 6 when a joint session of Congress would certify President-elect Joseph Bidens win.

In mid-December, Trump began actively promoting the Save America Stop the Steal rally. Look at this sample of his tweets:

Trying desperately to create a false cloud over the election outcome in at least one swing state, Trump focused on Georgia. On January 2, he called Georgia Secretary of State Brad Raffensperger a Trump supporter who had contributed to the campaign. Listen as he pressured Raffensperger to reverse the will of Georgia voters and threatened criminal prosecution if Raffensperger failed to comply:

And now lets listen to what Raffensperger a Trump supporter told him.

Getting nowhere with Raffensperger, the Trump Insurrection plan moved forward. On January 3, the day after his call with Raffensperger, he replied to a #StoptheSteal tweet from one of the rally organizers.

At the same time, Trump was pressuring Vice President Mike Pence relentlessly. He wanted Pence to defy the Constitution and, as presiding officer of the January 6 joint session, block final congressional certification of the election.

Danger was in the air. As Trump was tweeting on January 3, the US Capitol Police warned of the potential for violence at the rally, with Congress itself as the target.

On January 4, the National Park Service increased the crowd estimate on the rally permit from 5,000 to 30,000. The US Capitol Police chief asked for permission to put the National Guard on emergency standby, but was denied.

And take a look at the unusual memo that Acting Secretary of Defense Christopher Miller whom Trump had installed shortly after every major news organization had called the election in Bidens favor issued that day to his secretary of the army. It required Millers personal authorization before the DC National Guard could employ riot control agents and other tactics, including ballistic protection equipment such as helmets and body armor.

January 5 was a busy day:

On the morning of January 6 Trump Insurrection Day he got an early start with a tweet at 8:17 a.m. that put Pence in the crosshairs.

Later that morning, Pence told Trump that he would not comply with his unconstitutional demand to overturn the election. As Trump prepared to speak at the rally, his surrogates warmed up the crowd actively promoting insurrection. Look at the video:

Now that you have the context of the timeline, lets watch and listen to key excerpts from Trumps speech again. It began shortly before noon.

At 1:26 p.m. less than 30 minutes after Trumps speech had ended his mob had already reached the Capitol and the US Capitol Police ordered the evacuation of the complex.

At 1:34 p.m. DC Mayor Muriel Bowser asked the secretary of the army for more federal help to deal with the mob. Almost an hour later, Acting Defense Secretary Miller still had not approved the request.

At 1:49 p.m. Trump was so proud that his incitement had succeeded, he retweeted a video of his speech.

Trump didnt appear publicly until 4:17 p.m. three hours after the attack began. Rather than condemn his insurrectionists, he tweeted a video to the mob, saying: I know your pain. I know youre hurt. We had an election that was stolen from us. It was a landslide election and everyone knows it, especially the other sideIts a very tough period of time. Theres never been a time like this where such a thing happened where they could take it away from all of us from me, from you, from our country. This was a fraudulent election, but we cant play into the hands of these people. We have to have peace. So go home. We love you. Youre very special. Youve seen what happens. You see the way others are treated that are so bad and so evil.

And at 6:01 p.m. Trump tweeted: These are the things and events that happen when a sacred landslide election victory is so unceremoniously & viciously stripped away from great patriots who have been badly & unfairly treated for so long. Go home with love & in peace. Remember this day forever!

Now lets hear live testimony from law enforcement witnesses:

Mike Pence didnt have the courage to do what should have been done to protect our Country and our Constitution, giving States a chance to certify a corrected set of facts, not the fraudulent or inaccurate ones which they were asked to previously certify. USA demands the truth!

Heres a clip showing the crowd chanting Hang Mike Pence, the mobs makeshift gallows, and Goodmans heroism.

Lets also hear from these elected representatives and their staffs:

At 7:00 p.m., dozens of police officers had been injured in the Trump Insurrection, and people had died when Sen. Lee got another call intended for Sen. Tuberville. This time, Rudy Giuliani called the same wrong number that Trump had called when he mistakenly reached Sen. Lee five hours earlier. Giuliani left this message on Sen. Lees phone:

Sen. Tuberville? Or I should say Coach Tuberville. This is Rudy Giuliani, the presidents lawyer. Im calling you because I want to discuss with you how theyre trying to rush this hearing and how we need you, our Republican friends, to try to just slow it down so we can get these legislatures to get more information to you. I know theyre reconvening at 8 tonight, but itthe only strategy we can follow is to object to numerous states and raise issues so that we get ourselves into tomorrow ideally until the end of tomorrow.

Now lets hear from elected representatives reflecting on what happened that day:

Lets look at a video excerpt of his January 19 speech from the Senate floor:

The mob was fed lies. What were the lies? And since he used the passive voice, who fed those lies to the mob?

They were provoked by the president and other powerful people. How did Trump provoke the mob? And who are the other powerful people he referenced?

And they tried to use fear and violence to stop a specific proceeding of the first branch of the federal government which they did not like. Is that how American democracy is supposed to work after an election?

What blowback has he received from Trump and fellow Republicans after making that statement?

On January 6, 2021 a violent mob attacked the United States Capitol to obstruct the process of our democracy and stop the counting of presidential electoral votes. This insurrection caused injury, death and destruction in the most sacred space in our Republic.

Much more will become clear in coming days and weeks, but what we know now is enough. The President of the United States summoned this mob, assembled the mob, and lit the flame of this attack. Everything that followed was his doing. None of this would have happened without the President. The President could have immediately and forcefully intervened to stop the violence. He did not. There has never been a greater betrayal by a President of the United States of his office and his oath to the Constitution.

What blowback has she received from Trump and fellow Republicans after telling the truth and voting to impeach Trump?

What recriminations have the other nine Republicans in the House endured since joining with Rep. Cheney in voting to impeach Trump?

This time the Trump Insurrection failed. But America cant risk a sequel. After a successful attack on democracy, no one is left to hold the perpetrators accountable.

So now you know the answer to the question How did this happen in America? But you also know that theres a more urgent one: Are there enough Republicans in the Senate willing to keep it from happening again?

Listen to Steven Harper and Bill Moyers in Conversation. December 10, 2020

Visit link:

The Long Read The Trial of Donald Trump BillMoyers.com - BillMoyers.com

Posted in Donald Trump | Comments Off on The Long Read The Trial of Donald Trump BillMoyers.com – BillMoyers.com

Federal executions at end of Donald Trumps term were likely COVID-19 super-spreading events – The Boston Globe

Posted: at 8:00 am

Other staff members, including those brought in to help with executions, also spread tips to their colleagues about how they could avoid quarantines and skirt public health guidance from the federal government and Indiana health officials.

The executions at the end of Donald Trumps presidency, completed in a short window over a few weeks, likely acted as a superspreader event, according to the records reviewed by AP. It was something health experts warned could happen when the Justice Department insisted on resuming executions during a pandemic.

___

Its impossible to know precisely who introduced the infections and how they started to spread, in part because prisons officials didnt consistently do contact tracing and havent been fully transparent about the number of cases. But medical experts say its likely the executioners and support staff, many of whom traveled from prisons in other states with their own virus outbreaks, triggered or contributed both in the Terre Haute penitentiary and beyond the prison walls.

Of the 47 people on death row, 33 tested positive between Dec. 16 and Dec. 20, becoming infected soon after the executions of Alfred Bourgeois on Dec. 11 and Brandon Bernard on Dec. 10, according to Colorado-based attorney Madeline Cohen, who compiled the names of those who tested positive by reaching out to other federal death row lawyers. Other lawyers, as well as activists in contact with death row inmates, also told AP they were told a large numbers of death row inmates tested positive in mid-December.

In addition, at least a dozen other people, including execution team members, media witnesses and a spiritual adviser, tested positive within the incubation period of the virus, meeting the criteria of a superspreader event, in which one or more individuals trigger an outbreak that spreads to many others outside their circle of acquaintances. The tally could be far higher, but without contact tracing its impossible to be sure.

Active inmate cases at the Indiana penitentiary also spiked from just three on Nov. 19 the day Orlando Cordia Hall was put to death to 406 on Dec. 29, which was 18 days after Bourgeois execution, according to Bureau of Prisons data. The data includes the inmates at the high-security penitentiary, though the Bureau of Prisons has never said whether it included death row inmates in that count.

In all, 726 of the approximately 1,200 inmates at the United States Penitentiary at Terre Haute have tested positive for COVID-19 since the start of the pandemic, according to Bureau of Prisons data. Of them, 692 have recovered.

___

Advocates and lawyers for the inmates, a Zen Buddhist priest who was a spiritual adviser for one prisoner, and even the families of some of the victims fought to delay the executions until after the pandemic. Their requests were rebuffed repeatedly and their litigation failed. And some got sick.

Witnesses, who were required to wear masks, watched from behind glass in small rooms where it often wasnt possible to stand six feet apart. They were taken to and from the death-chamber building in vans, where proper social distancing often wasnt possible. Passengers frequently had to wait in the vans for an hour or more, with windows rolled up and little ventilation, before being permitted to enter the execution-chamber building. And in at least one case, the witnesses were locked inside the execution chamber for more than four hours with little ventilation and no social distancing.

Prison staff told their colleagues they should first get on planes, go back to their homes and then they could take a test, according to two people familiar with the matter. If they were positive, they said, they could just quarantine and wouldnt be stuck in Terre Haute for two weeks, said the people, who could not publicly discuss the private conversations and spoke to AP on condition of anonymity.

Following Halls execution in November, only six members of the execution team opted to get coronavirus tests before they left Terre Haute, the Justice Department said in a court filing. The agency said they all tested negative. But days later, eight members of the team tested positive for the virus. Five of the staff members who had tested positive were brought back to Terre Haute for more executions a few weeks later.

Yusuf Ahmed Nur, the spiritual adviser for Hall, stood just feet away inside the execution chamber when Hall was executed on Nov. 19. He tested positive for the virus days later.

Writing about the experience, Nur said he knew he would be putting himself at risk, but that Hall had asked him to be at his side when he was put to death. He, and Halls family, felt obliged to be there.

I could not say no to a man who would soon be killed, Nur wrote. That I contracted COVID-19 in the process was collateral damage of executions during a pandemic.

Later, two journalists tested positive for the virus after witnessing other executions in early December, then had contact with activists and their own loved ones, who later tested positive as well. Despite being informed of the diagnoses, the Bureau of Prisons knowingly withheld the information from other media witnesses and decided not to initiate any contact tracing efforts.

___

By mid-December, prison officials said that both Corey Johnson and Dustin Higgs were sick. They were the last two prisoners to be executed, just days before President Joe Biden took office.

Death row was put on lockdown after their results, inmates told Ashley Kincaid Eve, a lawyer and anti-death penalty activist. But even though they had also tested positive, she said Higgs and Johnson were still moved around the prison potentially infecting guards accompanying them so they could use phones and email to speak with their lawyers and families as their execution dates approached. Eve said prisons officials may have worried a court would delay the executions on constitutional ground if that access was denied.

In response to questions from the AP, the Bureau of Prisons said staff members who dont experience symptoms are clear to work and that they have their temperatures taken and are asked about symptoms before reporting for duty. (The AP has previously reported that staff members at other prisons were cleared with normal temperatures even when thermometers showed hypothermic readings.)

The agency said it also conducts contact training in accordance with federal guidance and that if staff are circumventing this guidance, we are not aware.

Officials said staff members were required to participate in contact tracing if they met the criteria for it and agency officials couldnt compel employees to be tested.

We cannot force staff members to take tests, nor does the CDC recommend testing of asymptomatic individuals, an agency spokesperson said, referring to the Centers for Disease Control and Prevention.

The union for Terre Haute employees declined to comment, saying it did not want to get into the public fray of this whole issue.

Elsewhere, union officials have long complained about the spread of the coronavirus through the federal prison system, as well as a lack of personal protective equipment and room to isolate infected inmates. Some of those issues have been alleviated, but containing the virus continues to be a concern at many facilities.

___

No more executions have yet been scheduled under Biden. The Bureau of Prisons has repeatedly refused to say how many other people have tested positive for the coronavirus after the last several executions. And the agency would not answer questions about the specific reasoning for withholding the information from the public, instead directing the AP to file a public records request.

The Bureau of Prisons said it also took extensive efforts to mitigate the transmission of the virus, including limiting the number of media witnesses and adding an extra van for the witnesses to space them out.

It has argued witnesses were informed social distancing may not be possible in the execution chamber and that witnesses and others were required to wear masks and were offered additional protective equipment, like gowns and face shields. The agency also refused to answer questions about whether Director Michael Carvajal or any other senior leaders raised concerns about executing 13 people during a worldwide pandemic that has killed more than 450,000 in the U.S.

Still, it appears their own protocols werent followed. After a federal judge ordered the Bureau of Prisons to ensure masks were worn during executions in January, the executioner and U.S. marshal in the death chamber removed their masks during one of the executions, appearing to violate the judges order. The agency argued they needed to do so to communicate clearly and that they only removed their masks for a short time and disputes that it violated the order.

___

In a Nov. 24 court filing on the spread of COVID at Terre Haute, Joe Goldenson, a public health expert on the spread of disease behind bars, said hundreds of staff participated in one way or another at each execution, including around 40 people on execution teams and those on 50-person specialized security teams who traveled from other prisons nationwide. He said he had warned earlier that executions were likely to become a superspreader.

Medical and public health experts repeatedly called on the Justice Department to delay executions, arguing the setup at prisons made them especially vulnerable to outbreaks, including because social distancing was impossible and health care substandard.

These are the type of high-risk superspreader events that the (American Medical Association) and (the Centers for Disease Control and Prevention) have been warning against throughout the pandemic, James L. Madara, the executive vice president of the AMA, wrote to the Department of Justice on Jan. 11, just before the last three federal executions were carried out.

___

Tarm reported from Chicago and Sisak reported from New York.

_____

On Twitter, follow Michael Tarm at twitter.com/mtarm, Michael Balsamo at http://www.twitter.com/MikeBalsamo1 and Michael Sisak at twitter.com/mikesisak.

The rest is here:

Federal executions at end of Donald Trumps term were likely COVID-19 super-spreading events - The Boston Globe

Posted in Donald Trump | Comments Off on Federal executions at end of Donald Trumps term were likely COVID-19 super-spreading events – The Boston Globe

Trump parts with impeachment lawyers a week before trial – The Associated Press

Posted: at 8:00 am

WASHINGTON (AP) Former President Donald Trump has parted ways with his lead impeachment lawyers just over a week before his Senate trial is set to begin, two people familiar with the situation said Saturday.

Butch Bowers and Deborah Barbier, both South Carolina lawyers, are no longer with Trumps defense team. One of the people described the parting as a mutual decision that reflected a difference of opinion on the direction of the case. Both insisted on anonymity to discuss private conversations.

One said new additions to the legal team were expected to be announced in a day or two.

The upheaval injects fresh uncertainty into the makeup and strategy of Trumps defense team as he prepares to face charges that he incited the insurrection at the U.S. Capitol on Jan. 6. However, all but five Senate Republicans this week voted in favor of an effort to dismiss the trial before it even started, making clear a conviction of the former president is unlikely regardless of his defense team.

Greg Harris and Johnny Gasser, two former federal prosecutors from South Carolina, are also off the team, one of the people said.

According to a different person with knowledge of the legal hires, Bowers and Barbier left the team because Trump wanted them to use a defense that relied on allegations of election fraud, and the lawyers were not willing to do so. The person was not authorized to speak publicly about the situation and requested anonymity.

Trump has struggled to find attorneys willing to defend him after becoming the first president in history to be impeached twice. He is set to stand trial the week of Feb. 8 on a charge that he incited his supporters to storm Congress before President Joe Bidens inauguration in an attempt to halt the peaceful transition of power.

After numerous attorneys who defended him previously declined to take on the case, Trump was introduced to Bowers by one of his closest allies in the Senate, South Carolina Sen. Lindsey Graham.

Bowers, a familiar figure in Republican legal circles, had years of experience representing elected officials and political candidates, including then-South Carolina Gov. Mark Sanford against a failed impeachment effort that morphed into an ethics probe.

Bowers and Barbier did not immediately return messages seeking comment Saturday evening.

Republicans and Trump aides have made clear that they intend to make a simple argument in the trial: Trumps trial is unconstitutional because he is no longer in office.

While Republicans in Washington had seemed eager to part ways with Trump after the deadly events of Jan. 6, they have since eased off of their criticism, weary of angering the former presidents loyal voter base.

CNN was first to report the departure of the lawyers.

____

Associated Press writer Meg Kinnard in Columbia, South Carolina, contributed to this report.

Visit link:

Trump parts with impeachment lawyers a week before trial - The Associated Press

Posted in Donald Trump | Comments Off on Trump parts with impeachment lawyers a week before trial – The Associated Press

CF Industries Holdings, Inc. Announces Dates for Full Year and Fourth Quarter 2020 Results and Conference Call – Yahoo Finance

Posted: at 7:59 am

TipRanks

Lets talk about risk and the big picture. Its an appropriate time, as the big risk presented by the COVID-19 pandemic is finally receding thanks to the ongoing vaccination program. COVID is leaving behind an economy that was forced into shutdown one year ago while in the midst of a great expansion, boosted by the deregulation policies. While the new Biden Administration is busy reversing many Trump policies, at least for now the economy is rebounding. And this brings us to risk. A time of economic growth and rebound is a forgiving time to move toward risk investments, as general economic growth tends to lift everything. Two strategists from JPMorgan have recently chimed in, promoting the view that the markets fundamentals are still sound, and that small- to mid-cap sector is going to keep rising. First, on the general conditions, quant strategist Dubravko Lakos-Bujas wrote, Although the recent technical selloff and short squeeze is receiving a lot of attention, we believe the positive macro setup, improving fundamentals and COVID-19 outlook, strength of the US consumer, as well as the reflation theme remain the bigger forces at play. Not only should this drive further equity upside, but it remains favorable for continued rotation into economic reopening Building on this, Eduardo Lecubarr, chief of the Small/Mid-Cap Strategy team, sees opportunity for investors now, especially in the smaller value stocks. We stick to our view that 2021 will be a stockpickers paradise with big money-making opportunities if you are willing to go against the grain Many macro indicators did fall in January but SMid-Caps and equities in general continued to edge higher, Lecubarr noted. And if you are prone to look at high-risk, small- to mid-cap stocks, youll find yourself drawn to penny stocks. The risk involved with these plays scares off the faint hearted as very real problems like weak fundamentals or overwhelming headwinds could be masked by the low share prices. So, how should investors approach a potential penny stock investment? By taking a cue from the analyst community. These experts bring in-depth knowledge of the industries they cover and substantial experience to the table. Bearing this in mind, we used TipRanks database to find two compelling penny stocks, according to Wall Street analysts. Both tickers boast a Strong Buy consensus rating and could climb over 200% higher in the year ahead. CNS Pharmaceuticals (CNSP) We will start with CNS Pharmaceuticals, a biotechnology company with a focus on the treatment of glioblastomas, a class of aggressive tumors that attack the braid and spinal cord. These cancers, while rare, are almost always terminal, and CNS is working a new therapy designed to more effectively cross the blood-brain barrier to attack glioblastoma. Berubicin, CNSs flagship drug candidate, is an anthracycline, a potent class of chemotherapy drugs derived from the Streptomyces bacteria strains, and used in the treatment of a wide variety of cancers. Berubicin is the first drug in this class to show promise against glioblastoma cancers. The drug candidate has completed its Phase 1 clinical trial, in which 44% of patients showed a clinical response. This number included one patient who showed a Durable Complete Response, defined as a demonstrated lack of detectable cancer. Following the success of the Phase 1 study, CNS applied for, and received, FDA approval of its Investigational New Drug application. This gives the company the go-ahead to conduct a Phase 2 study on adult patients, an important next step in the development of the drug. CNS plans to start the mid-stage trial in 1Q21. Based on the potential of the companys asset in glioblastoma, and with its share price at $2.22, several analysts believe that now is the time to buy. Among the bulls is Brooklines 5-star analyst Kumaraguru Raja who takes a bullish stance on CNSP shares. Until now, the inability of anthracyclines to cross the blood brain barrier prevented its use for treatment of brain cancers. Berubicin is the first anthracycline to cross the blood-brain barrier in adults and access brain tumors Berubicin has promising clinical data in a Phase 1 trial in recurrent glioblastoma (rGBM) and has Orphan drug designation for treatment of malignant gliomas from the FDA. We model approval of Berubicin for treatment of recurrent glioblastoma in 2025 based on the Phase 2 data with 55% probability of success for approval. We model peak sales of $533 million in 2032, Raja opined. CNS pipeline also includes WP1244 (novel DNA binding agent) that is 500x more potent than daunorubicin in inhibiting tumor cell proliferation is expected to enter the clinic in 2021 In vivo testing in orthotopic models of brain cancer showed high uptake of WP1244 by brain and subsequent antitumor activity, the analyst added. To this end, Raja rates CNSP a Buy, and his $10 price target implies room for a stunning 350% upside potential in the next 12 months. (To watch Rajas track record, click here) What does the rest of the Street have to say? 3 Buys and 1 Hold add up to a Strong Buy consensus rating. Given the $8.33 average price target, shares could climb ~275% in the year ahead. (See CNSP stock analysis on TipRanks) aTyr Pharma (LIFE) The next stock were looking at, aTyr Pharma, has a focus on inflammatory disease. Its leading drug candidate, ATYR1923, is a Neuropilin-2 (NRP2) agonist, working through the receptor proteins expressed by the NRP2 gene. These pathways are important for cardiovascular development and disease, and play a role in the inflammatory lung disease pulmonary sarcoidosis. In December, the company reported that the drug candidate had completed enrollment of 36 patients in a Phase 1b/2a clinical trial, testing the drug in the treatment of pulmonary sarcoidosis. Results of the current study are expected in 3Q21, and will inform further trials of ATYR1923, including against other forms of inflammatory lung disease. On a more immediate note, in early January the company announced top-line results of another Phase 2 clinical involving ATRY1923 this time in the treatment of patients hospitalized with severe respiratory complications from COVID-19. The results were positive, showing that a single dose of ATYR1923 (at 3 mg/kg) resulted in a 5.5-day median recovery time. Overall, of the patients dosed in this manner, 83% saw recovery in less than one week. Covering LIFE for Roth Capital, 5-star analyst Zegbeh Jallah noted, We like the risk profile here, with two shots on goal, and updated data details from the COVID study is expected in the coming months. Also announced recently, is that data from aTyr's Pulmonary Sarcoidosis program, will be reported in 3Q21 the success of either of these studies could result in a doubling or more of the market cap as these opportunities appear to barely be accounted for by investors. In line with his optimistic approach, Jallah gives LIFE shares a Buy rating and his $15 price target suggests an impressive 277% potential upside for the coming year. (To watch Jallahs track record, click here) Other analysts are on the same page. With 2 additional Buy ratings, the word on the Street is that LIFE is a Strong Buy. On top of this, the average price target is $13.33, suggesting robust growth of ~236% from the current price of $3.97. (See LIFE stock analysis on TipRanks) To find good ideas for penny stocks trading at attractive valuations, visit TipRanks Best Stocks to Buy, a newly launched tool that unites all of TipRanks equity insights. Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

Go here to read the rest:

CF Industries Holdings, Inc. Announces Dates for Full Year and Fourth Quarter 2020 Results and Conference Call - Yahoo Finance

Posted in Cf | Comments Off on CF Industries Holdings, Inc. Announces Dates for Full Year and Fourth Quarter 2020 Results and Conference Call – Yahoo Finance

Having an underlying health condition doesn’t mean we move up the COVID-19 vaccine line – USA TODAY

Posted: at 7:59 am

Gunnar Esiason and Emily Kramer-Golinkoff, Opinion contributors Published 7:00 a.m. ET Feb. 4, 2021

There are many questions surrounding Covid-19 vaccines, one of which is whether vaccines can be mixed and matched. Veuers Johana Restrepo has more. Buzz60

When it comes to getting vaccinated, why are many Americans with cystic fibrosis behind people working remotely, smokers, and cannabis growers?

In March, the term underlying condition was used toreassurehealthy Americans about their risk as COVID-19 overwhelmed New York Citys hospitals. Media reports saidoverandoverthat underlying health conditions presented an enormous amount of risk for Americans.

Yet, in many states people living with serious underlying conditions are still waiting for COVID-19 vaccines, prioritized below individuals with lower risk. Suddenly, it seems underlying health conditions are considered nothigh risk enough.

We live with cystic fibrosis (CF), a rare and fatal genetic disease associated with respiratory decline and failure. In 2019, the median age of death for individuals with CF in the United States was32.4 years old. And that'sunder the best of circumstances, notduring a pandemic.

When cases of COVID-19 started mounting nationwide, our patient community wasquickly urgedto stock up on supplies and stay home.Like the millions of Americans with underlying conditions, our goal was topreventexposure to COVID-19.

More than 30,000 people in the United States have CF. As of mid-January, at least799 individuals with CF have contracted COVID-19 in the U.S. with almost15% requiring hospitalization,according to a webinarhostedby the Cystic Fibrosis Foundation. According to preliminary data from theEuropean Cystic Fibrosis Society,the hospitalization rate for confirmed COVID-19 cases in Europeis almost 28%.

The risk for bad outcomes from COVID-19 increasesefor CF patientswith advanced lung disease, diabetes, or if they have received a double lung transplant.

Clearly, access to COVID-19 vaccines couldsubstantially reduce the risk of severe outcomesfrom the virus.

We have watched lower risk populations,including hospital employeeswithout direct patient careresponsibilities, universityfacultyable to teach remotely, and vaccine chasers receive their shots.

The specific prioritization varies state by state, but people with serious underlying conditions are finding themselves at the back of the line across the country, often because they are younger in age.

In Pennsylvania, people with CF are waiting in line behindsmokersand in Maryland, they are waiting behindcannabis growers. InWashingtonandMichigan, people with CF may have to wait until the spring or summer.

We allowed the opioid epidemic to play out: FDA's Janet Woodcock failed to stop the opioid epidemic

In some parts of the country, likeNorth CarolinaandCalifornia, vaccines are beingallocated by agerather thanrisk of serious outcomes, thereby leaving people with life-shortening diseases like CF behind.

Why are people with underlying health conditions who may have substantial risk for bad outcomes from COVID-19 being forced to wait for vaccines?

It is because we are stuck in a high-risk limbo.In some ways, orders to stay at home as much as possible worked, but now they are being used against us.

Because of our conditionssmall patient population sizeand our strict adherence to social distancing guidelines, states don't have complete information when it comes to the risks we face aftercontracting COVID-19. Imperfect data should not beused to set policy.

With advanced stage disease, I (Emily) am at particularly high risk. I have not left my house aside from a daily masked and socially distanced walk since March. I have not stepped foot in a grocery store or restaurant, and I have had to convert all of my medical care to telehealth. While telehealth has many benefits, the reality remains that a zoom call with ones doctors is not a substitute for in-person care, nor is it always possible.

Emily Kramer-Golinkoff in Philadelphia in July 2018.(Photo: Cheyenne Gil)

Disability advocates are rightly frustrated with vaccine allocation. CF is not the only condition to be disadvantaged in the rollout. People living with asthma, dementia, hypertension, liver disease, andother rareconditionsare also having towait behind healthy Americans.

Only one of us (Emily) has been able to receive the first dose of a vaccine, while the other (Gunnar) has had no luck so far. We are a microcosm of the frustration our patient community faces in gaining access to vaccines.

Instead, we aretold to stay home.

Now, it is almost as if staying home is presented to us as an alternative to vaccination. Chronic conditions often require in-person medical care that put us at high risk for exposure. In addition, people with CF and their family members rely on jobs for rent, food and health insurance just like everyone else that cannot always be done remotely. They alsohave children that go to schooland require child care. Just staying home is simply untenable for many.

Beyond the practical considerations, the suggestion that people with underlying conditions just stay home while we wait for later phases of the rollout is a solution steeped in discrimination. Providing vaccinations to lower risk people makes society accessible again for able-bodied people, while those of us with underlying medical conditions and disabilities are tucked away, expected to put our lives on hold, and wait.

Virginia fails to protect elderly: My parents caught COVID while vaccines languish unused

The insistence that we simply stay home denies our worth and value to society and treats us as second class citizens. The effect is a perpetuation of systemic ableism and widening of pre-existing inequity among sick and disabled populations.

Just staying home is not a substitute for vaccines.

Gunnar Esiason in Hanover, New Hampshire, in February 2020.(Photo: Family handout)

Highly effective vaccines are finally available. Now the onus is on policy makers to allocate them justly and equitably. That includes providing them to people with serious underlying conditions. This is particularly critical now as new coronavirusvariantsemerge in the US.

After all, for many of us with serious underlying conditions, a vaccine now versus in a few weeks or months can be the difference between life and death.

Gunnar Esiason, aMaster of Business Administration/Master of Public Healthcandidate at the Tuck School of Business at Dartmouth, lives with cystic fibrosis and is a rare disease patient leader with the BoomerEsiason Foundation. Follow him on Twitter @G17Esiason

Emily Kramer-Golinkoff, a Master of Bioethics,lives with advanced stage cystic fibrosis and is theco-founder of Emilys Entourage, which promotes research and drug development for Cystic Fibrosis,and a patient advocate and speaker. Follow Emily on Twitter at @emilykg1 and Emilys Entourage at @EmilysEntourage.

Autoplay

Show Thumbnails

Show Captions

Read or Share this story: https://www.usatoday.com/story/opinion/2021/02/04/covid-19-vaccinations-underlying-conditions-cystic-fibrosis-column/4376586001/

View post:

Having an underlying health condition doesn't mean we move up the COVID-19 vaccine line - USA TODAY

Posted in Cf | Comments Off on Having an underlying health condition doesn’t mean we move up the COVID-19 vaccine line – USA TODAY

CF PharmTech and Chengdu Shangyi Launch the "Home-Based Recovery Program for Discharged Covid-19 Patients" and Announce Today’s Global…

Posted: at 7:59 am

In April 2020, CF PharmTech and Chengdu Shangyi launched the "Home-Based Recovery Program for Discharged Covid-19 Patients". Under the guidance of Professor Li Jian'an, a member of the American Academy of Medical Sciences and Director of the Rehabilitation Medical Center of the First Affiliated Hospital of Nanjing Medical University, they successfully conducted studies of discharged Covid-19 patients using sports rehabilitation remote monitoring by "R Plus Health" App.

The clinical results exceeded everyone's expectations. Professor Li Jian'an concluded that the effect of sports rehabilitation monitoring for patients using the App was comparable to the effect from care given patients in the "Mobile Cabin Hospital" in Wuhan. The companies jointly launch the free "R Plus Health" App globally today.

The App is the world's clinically proven and effective, home-based rehabilitation treatment for Covid-19 patients. It is the first "patented digital therapy" approved by the NMPA(National Medical Products Administration). The main function of the App is its remote intelligent cardiopulmonary/muscle/nutrition assessment, combining the wearable equipment with prepackaged medicinal supplements.

The App will assist in improving the cardiopulmonary endurance and immunity of Covid-19 patients, susceptible populations, high-risk contacts, elderly people and children with poor immunity. Once users register, the App carries out intelligent assessments including questionnaires, and cardiopulmonary endurance and body function tests. After an evaluation, users can access a personalized exercise program including sports type, intensity, length of time and frequency. Users simply need to follow the sports training videos and do the exercises. The effect will be enhanced if the App is connected to intelligent equipment.

Since the outbreak of Covid-19, more than 100 million people have been diagnosed worldwide, and the number of infected individuals is increasing rapidly. It has become a global pandemic. Join the "R Plus Health" App to enhance physical fitness, improve immunity and fight against the coronavirus.

How to download:1.Search for "R Plus Health" App in the Apple Store or Google Play2.Click the link: https://download.rplushealth.cn/app/patient

SOURCE CF PharmTech, Inc.

See original here:

CF PharmTech and Chengdu Shangyi Launch the "Home-Based Recovery Program for Discharged Covid-19 Patients" and Announce Today's Global...

Posted in Cf | Comments Off on CF PharmTech and Chengdu Shangyi Launch the "Home-Based Recovery Program for Discharged Covid-19 Patients" and Announce Today’s Global…

Philadelphia Phillies: Could Scott Kingery end up as the everyday CF? – Section 215

Posted: at 7:59 am

Once regarded as one of the Philadelphia Phillies top young talents, Scott Kingery did not have the 2020 that we were all expecting from him. After a nasty bout with COVID-19 leading into the shortened season, Kingery simply never got his feet under him. He finished the year with career-worsts across the board, slashing a measly .159/.283/.511. Kingerys defense was equally as suspect, as he actually finished with a negative defensive WAR on the year (-0.4).

It was a brutal 2020 campaign for the young infielder/outfielder, one that was constantly riddled with nagging injuries and bouts of inconsistencies. Anytime it looked like he was finally starting to find a rhythm, hed immediately fall back into a slump highlighted by lots of strikeouts and miscues in the field.

With all that said, theres still little reason to be 100% out on the former second round pick. He had an encouraging season in 2019 (career-high .788 OPS, 2.8 WAR), and hes still one of the better athletes on the Philadelphia Phillies roster. While he might struggle to snag himself an everyday role at second base the position he won a Gold Glove at in the minor leagues theres a possibility he finds himself a new starting gig in the Phillies outfield this season.

With Didi Gregorius now under contract for the next two seasons, the Phillies actually have a bit of a logjam when it comes to their infield. Didi is obviously the teams shortstop, Alec Bohm and Rhys Hoskins should be locking down the corners, and then Jean Segura likely takes second base. While the Phillies could in theory rotate Segura and Kingery at 2B to get them both playing time (like they did in 2020), it might make more sense for Joe Girardi to finally commit to Kingery as a full-time center fielder.

Due to his elite athleticism, Kingery has spent a good amount of time in the outfield throughout his three-year career. Hes logged 636 career innings as an outfielder, with 547 of them coming in center. While hes not been *great* by any stretch of the imagination out in CF, he did post a perfect fielding percentage at the position in 2020, at least showing signs of potential.

While the infield might be a more natural fit for Kingery based on his minor league experience, the Phillies are lacking in outfield depth. Andrew McCutchen is on his last legs, Roman Quinn can be a liability at times, and Adam Haseley has still failed to earn the trust of Girardi as an everyday option himself.

Barring any sort of last minute outfield additions, the Phillies would be wise to at least continue to cross-train Kingery as a second baseman and center fielder. On days where McCutchen needs a rest, lining up Kingery and Haseley as the center and left fielders wouldnt be the worst thing in the world.

While most still share the belief that Kingery needs to get everyday reps at 2B to continue to develop, at some point, playing time starts to become a factor. As long as Segura remains on the roster, itll be tough for Scott to be the full-time starter at second base. If taking over CF means getting daily action in the lineup, its something the Phillies should consider.

Here is the original post:

Philadelphia Phillies: Could Scott Kingery end up as the everyday CF? - Section 215

Posted in Cf | Comments Off on Philadelphia Phillies: Could Scott Kingery end up as the everyday CF? – Section 215

CF & CFRP Market Report The demand for the Market will drastically increase in the Future Forecast 2025 KSU | The Sentinel Newspaper – KSU | The…

Posted: at 7:59 am

Kay Dee Market Insights (KDMI) recently published market research report on the globalCF & CFRP Market, this market research report provides detailed analysis of market drivers, challenges, opportunity analysis, and trends, along with various key insights into the market research report. The report on global CF & CFRP market demonstrates the important aspects that are anticipated to shape the growth of the market over the forecast period. The study also includes the analysis of the market size & forecast for the different segments and geographies.

The growth of this market is attributed towards major pertaining factors including: the increase in the demand for high-performance materials with high strength-to-weight ratio, good tensile strength, and electrical conductivity, the increasing use of carbon fiber composite materials in the aerospace industry, the rise in demand for lightweight vehicles so as to achieve fuel efficiency and production of electricity, the growing focus on renewable energy sources, exponential reduction in cost of carbon fibers, thegrowing demand for better performing products in the defense industry and the increasing focus on production of electricity from renewable source etc.

Access Exclusive Sample Report on CF & CFRP Market with Covid -19 Impacthttps://www.kdmarketinsights.com/sample/6891

The global CF & CFRP market research study aims to provide comprehensive analysis of market dynamics including the growth factors of the market which helps the clients to understand the market, market barriers & issues, industry trends and opportunities which can exhibit the current and future status of the market. Along with this, the report is also focused on the analysis of Porters Five Forces which defines the five forces including the buyers bargaining power, suppliers bargaining power, the threat of new entrants, the threat of substitutes, and degree of competition in the global CF & CFRP market.

Key Segments Covered in the Global CF & CFRP Market:

Market Forecast Analysis for 2019-2025

Growth Drivers & Barriers, Market Trends, Market Opportunities, Porters Five Forces Analysis, Trade Analysis

Market Overview, Industry Development, Market Maturity, Value Chain Analysis

Impact Analysis of Coronavirus Disease (COVID-19)

Regional & Country Level Analysis

Market Segment Trend and Forecast

Market Analysis and Various Recommendations

Key Market Driving Factors

Competitive Landscape: Company Market Share & Market Positioning, Company Profiling, Recent Industry News.

Impact of Coronavirus Disease (COVID-19) on Global CF & CFRP Market

The market research report explains the impact of coronavirus disease (COVID-19) on global CF & CFRP market, covering the major points of industry:

Impact analysis of COVID-19 on the global CF & CFRP market over the upcoming years.

Analysis of each region & country will be listed, to identify the issues caused by the coronavirus disease on the market.

Various strategies adopted by the major & prominent market players in order to survive in the situation of COVID-19 lockdown.

Explore Full Report With TOC and List of Figure of CF & CFRP Market with Covid -19 Impact https://www.kdmarketinsights.com/product/6891/cf-&-cfrp-market

Market Segmentation:

The research offers a comprehensive analysis of global CF & CFRP market with respect to following sub-markets:

By Source:

Virgin

Recycled

By End-use Industry:

Aerospace & Defense

Wind Energy

Automotive

Sporting Goods

Civil Engineering

Pipe & Tank

Marine

Electrical & Electronics

Medical

Others

ByRaw Material Type:

Pan-Based Carbon Fiber

Small-Tow (<24k)

Large-Tow (>24k)

Pitch-Based Carbon Fiber

Rayon-Based Carbon Fiber

ByResin Type:

Thermosetting CFRP

Epoxy

Polyester

Vinyl Ester

Others

Thermoplastic CFRP

Polypropylene

Polyethylene

Polyethylene Terephthalate

Others

By Manufacturing Process:

Lay-Up Process

Compression Molding Process

Resin Transfer Molding Process

Filament Winding Process

Injection Molding Process

Pultrusion Process

Others

Regional Information:

The report analyses the market by geographies i.e. North America, Europe, Asia Pacific, Latin America & Middle East & Africa. Further, the regions are fragmented into the country and regional groupings:

North America (U.S. & Canada)

Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand, and Rest of Asia Pacific)

Latin America (Brazil, Mexico, and Rest of Latin America)

Middle East & Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, and Rest of Middle East & Africa)

Competitive Landscape

The market research report highlights the competitive landscape of the global CF & CFRP market, market share and positioning of all the major players in the industry. In addition, the report also profiles various major & niche key market players in the global CF & CFRP market including:

Solvay

Hyosung

Formosa Plastic Corporation

Dowaksa

Kureha Corporation

Toray Industries Inc

Mitsubishi Chemical Holdings

Hexcel Corporation

Check Our Exclusive Offer and Get Instant Discount on CF & CFRP Market https://www.kdmarketinsights.com/discount/6891

About Us:

KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant, and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights.

Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.

Contact Us:

KD Market Insights

150 State Street, Albany,

New York, USA 12207

+1 (518) 300-1215

Email:sales@kdmarketinsights.com

Website:www.kdmarketinsights.com

Continued here:

CF & CFRP Market Report The demand for the Market will drastically increase in the Future Forecast 2025 KSU | The Sentinel Newspaper - KSU | The...

Posted in Cf | Comments Off on CF & CFRP Market Report The demand for the Market will drastically increase in the Future Forecast 2025 KSU | The Sentinel Newspaper – KSU | The…

The Third Sub Episode 71: Whitecaps make moves, CF Montreal continue to build, and some other MLS chatter – Between The Sticks

Posted: at 7:59 am

In Episode 71 of the Third Sub Podcast, Alexandre Gangue-Ruzic and Samuel Rowan dive into the latest Vancouver Whitecaps and MLS news from this past week, before finishing off with some more MLS kit chatter.

Welcome back to another episode of the Third Sub Podcast!

In this episode, Alex and Sam are back, as usual, this time to chat all things Vancouver Whitecaps and MLS.

Up first, they catch up on the Whitecaps news of the week, as they look at some of the confirmed transactions that have happened in the past week.

First, they look at a confirmed departure, as David Milinkovics contract was officially terminated this week, before looking at some of the names that signed new deals in the past week, as Andy Rose officially re-signed (and became an assistant coach for the Caps U19 team!), while Caps Super Draft pick David Egbo and longtime USL veteran Evan Newton signed deals to join the team.

After that, they look at how the CBA negotiations have progressed over the last week, giving some thoughts on the multiple extensions of the negotiating deadline by MLS, breaking down what sort of message this whole process has delivered.

To round off the episode, they then tip their hat to Club de Foot Montreal and the incredible work theyve put in behind the scenes to build a sneaky-good team, before devolving into some more MLS kit discussion and speculation.

If you have Twitter, make sure to check out The Third Sub Podcast @thirdsubpod!

The Third Sub can be found on Spotify, Google Play, Apple Podcasts and Anchor. It can also now be found on Breaker, Overcast, Pocket Casts and Radio Public, so if you have any of those platforms installed, you can now find it on them.

(We are no longer uploading to Soundcloud, but you can still find the first two episodes there, if interested.)

Apple Podcasts

Google Play

Breaker

Overcast

Pocket Casts

Like Loading...

Related

See the rest here:

The Third Sub Episode 71: Whitecaps make moves, CF Montreal continue to build, and some other MLS chatter - Between The Sticks

Posted in Cf | Comments Off on The Third Sub Episode 71: Whitecaps make moves, CF Montreal continue to build, and some other MLS chatter – Between The Sticks